Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-17-009835
Filing Date
2017-06-30
Accepted
2017-06-30 17:10:52
Documents
2
Period of Report
2017-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2226
2 ex24stratton.txt EX-24 1879
  Complete submission text file 0001179110-17-009835.txt   5345
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 8479376100
ABBOTT LABORATORIES (Issuer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1095 AVENUE OF THE AMERICAS, 8TH FLOOR NEW YORK NY 10036
Business Address
Stratton John G (Reporting) CIK: 0001385262 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-02189 | Film No.: 17943062